MIT Engineers Develop Heat-Resistant RNA Vaccines Using Artificial Intelligence
Researchers have developed a new AI-powered formulation for RNA vaccines that eliminates the need for an ultra-cold chain and can last up to a year at room temperature.
Massachusetts Institute of Technology engineers have designed a data-efficient artificial intelligence algorithm that stabilizes lipid nanoparticles to facilitate the distribution of RNA vaccines, making them resistant to high temperatures.
Overcoming the Cold Chain Challenge
One of the biggest disadvantages of RNA vaccines, which proved their effectiveness in the fight against Covid-19 and continue to be developed for many diseases such as cancer, has been their ultra-cold storage requirements.
However, MIT researchers have found a promising method that optimizes lipid nanoparticle formulations to overcome this limitation.
AI-Powered Formulation Process
The researchers worked with the MIT Computer Science and Artificial Intelligence Laboratory to develop a specialized algorithm capable of making predictions based on very small datasets.
This algorithm reduced the number of experiments required and accelerated the development process.
Resistance to High Temperatures
Thanks to this newly developed approach, the vaccines were able to maintain their stability at room temperature for up to a year or for about two months at approximately 100 degrees Fahrenheit.
This facilitates shipment to regions where cold storage facilities are unavailable.
Animal Experiments and Future Possibilities
When Covid-19 vaccines carried with these particles were administered to mice, they produced an immune response as strong as current vaccines. This study paves the way for innovative delivery methods such as microneedle patches, alongside room-temperature storage capabilities.